Sign in

CIK 0001630627

  • Accelerated filer

TREACE MEDICAL CONCEPTS, INC.

Sign in to watch
Ticker
TMCI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
FL
Entity type
Operating
EIN
471052611
Phone
+1 904-373-5940
Business address
100 PALMETTO PARK PLACE, PONTE VEDRA, FL, 32081
Open-market buys, last 90 days
$47,731
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$47,731. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Treace John T. +$48K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-10-20 Treace John T. Chief Executive Officer Sale −8,215 $25.37 $208K 5,886,753
2021-10-20 TIMBIE THOMAS E Director Sale −11,171 $25.18 $281K 2,249,069
2021-10-06 Ferguson Joe W. SVP, Research & Development Exercise or conversion +308,641 $0.10 $31K 419,756
2021-10-06 Ferguson Joe W. SVP, Research & Development Exercise or conversion · Stock Option (Right to Buy) −308,641 248,994
2021-10-01 Hanna Betsy Director Grant or award · Stock Option (Right to Buy) +17,750 17,750
2021-10-01 Jain Deepti Director Purchase · Stock Option (Right to Buy) +17,750 17,750
2021-09-17 Lubben Terry W. SVP, Operations Grant or award · Stock Option (Right to Buy) +135,000 135,000
2021-09-07 Treace John T. Chief Executive Officer Grant or award +408,816 408,816
2021-09-07 TIMBIE THOMAS E Director Gift −280,000 2,540,240
2021-09-07 TIMBIE THOMAS E Director Gift −280,000 2,260,240
2021-08-03 Berutti Aaron SVP, Sales Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-04-27 Ferguson Joe W. SVP, Research & Development Conversion +85,575 85,575
2021-04-27 Ferguson Joe W. SVP, Research & Development Other acquisition · Series A Preferred Stock +1,981 85,575
2021-04-27 Ferguson Joe W. SVP, Research & Development Conversion · Series A Preferred Stock −85,575 0
2021-04-27 Treace John T. Chief Executive Officer Conversion +299,510 11,171,385
2021-04-27 Treace John T. Chief Executive Officer Sale −5,253,805 $17.00 $89.3M 5,917,580
2021-04-27 Treace John T. Chief Executive Officer Other acquisition · Series A Preferred Stock +6,932 299,510
2021-04-27 Treace John T. Chief Executive Officer Conversion · Series A Preferred Stock −299,510 0
2021-04-27 TIMBIE THOMAS E Director Conversion +299,509 2,820,240
2021-04-27 TIMBIE THOMAS E Director Other acquisition · Series A Preferred Stock +6,931 299,509

Page 26 of 28 · 560 trades